文献速递脊柱外科创伤骨科骨肿瘤

局部应用万古霉素悬于纤维蛋白胶预防脊柱内固定术后手术部位感染:基于治疗概率加权模型的比较

The Effect of Local Administration of Vancomycin Suspended in Fibrin Glue for Prevention of Surgical Site Infection After Spinal Instrumentation: Comparison by Probability of Treatment Weighting Model.
PubMed 文献 · Spine (Phila Pa 1976) · 2022-12-28

这项回顾性队列研究纳入264例后路脊柱内固定手术患者,比较术中局部应用万古霉素悬于纤维蛋白胶与未应用者的手术部位感染率。应用组感染率2.2%低于未应用组8.5%,经逆概率治疗加权调整后调整比值比为0.25(95%CI 0.0768-0.91,P=0.03)。多因素logistic回归显示该治疗与较低的感染 odds 显著相关(OR 0.2,95%CI 0.05-0.85,P=0.03)。

要点

  • 264例后路脊柱内固定患者中,134例局部应用万古霉素悬于纤维蛋白胶,130例未应用。
  • 应用组手术部位感染率2.2%,未应用组8.5%。
  • 加权调整后OR 0.25(95%CI 0.0768-0.91,P=0.03),多因素分析OR 0.2(95%CI 0.05-0.85,P=0.03)。

核心结论

  • 局部应用万古霉素悬于纤维蛋白胶与脊柱内固定手术患者较低的手术部位感染 odds 显著相关。

研究设计与样本

  • 回顾性队列研究,纳入264例因退变性疾病、脊柱创伤或肿瘤行后路脊柱内固定手术(伴或不伴融合)的患者。
  • 采用基于倾向评分的逆概率治疗加权多因素logistic回归模型评估疗效并控制混杂,并进行二次多因素logistic回归分析识别SSI危险因素。

主要发现

  • 134例患者术中局部应用万古霉素悬于纤维蛋白胶,130例未应用。
  • 应用组手术部位感染发生率为2.2%,未应用组为8.5%。
  • 经逆概率治疗加权调整后,调整比值比为0.25(95%CI 0.0768-0.91,P=0.03)。
  • 多因素logistic回归分析显示,局部应用万古霉素悬于纤维蛋白胶与较低的SSI odds 显著相关(OR 0.2,95%CI 0.05-0.85,P=0.03)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: A retrospective cohort study. OBJECTIVE: To compare the surgical site infection (SSI) rate in patients undergoing spinal instrumentation surgery who received vancomycin suspended in fibrin glue at the surgical site and those who did not. SUMMARY OF BACKGROUND DATA: The intrawound application of vancomycin powder for preventing SSI after spinal surgery remains controversial. Vancomycin suspended in fibrin glue is another option for local administration that may be effective. The present study assessed whether vancomycin suspended in fibrin glue could prevent SSI after spinal instrumentation surgery. MATERIALS AND METHODS: We enrolled patients who underwent posterior spinal instrumentation surgery with or without fusion for degenerative conditions, spinal trauma, or tumor. A multiple logistic regression model with inverse probability of treatment weighting based on propensity score was used to assess the efficacy of vancomycin suspended in fibrin glue and to account for confounding. A secondary multivariate logistic regression analysis was performed to identify the risk factors associated with SSI. RESULTS: Of the 264 patients enrolled in this study, 134 underwent application of vancomycin suspended in fibrin glue at the surgical site and 130 did not. The incidence of SSI was lower in patients who were treated with vancomycin suspended in fibrin glue (2.2% vs. 8.5%) even after inverse probability of treatment weighting adjustment (adjusted odds ratio: 0.25; 95% CI, 0.0768-0.91; P =0.03). Multivariate logistic regression analysis showed that the treatment with vancomycin suspended in fibrin glue was significantly associated with a lower odds of SSI (odds ratio: 0.2; 95% CI, 0.05-0.85; P =0.03). CONCLUSIONS: The administration of vancomycin suspended in fibrin glue was significantly associated with a lower likelihood of SSI in patients undergoing spinal instrumentation surgery.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Higashi T, Kobayashi N, Ide M, et al. The Effect of Local Administration of Vancomycin Suspended in Fibrin Glue for Prevention of Surgical Site Infection After Spinal Instrumentation: Comparison by Probability of Treatment Weighting Model. Spine (Phila Pa 1976). 2022. PMID: 36728797. doi:10.1097/BRS.0000000000004561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。